Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Methods in Molecular Biology (Clifton, N.J.)
|
March 11, 2021
Single-Cell Analysis of BRAF<sup>V600E</sup> and NRAS<sup>Q61R</sup> Mutation Status in Melanoma Cell Lines as Method Generation for Circulating Melanoma Cells
Joseph W Po, Yafeng Ma, Alison W S Luk, et al.
Breast (Edinburgh, Scotland)
|
November 8, 2020
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio
Clara Inkyung Lee, Siew Kee Low, Ricardo Maldonado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study
Peter Fox, Rosemary L Balleine, Clara Lee, et al.
Clinical Pharmacokinetics
|
November 16, 2013
Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study
Jacqueline S L Kloth, Heinz-Josef Klümpen, Huixin Yu, et al.
The Lancet. Oncology
|
September 18, 2024
Sequential [<sup>177</sup>Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study
Arun A Azad, Mathias Bressel, Hsiang Tan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Methods in Molecular Biology (Clifton, N.J.)
|
March 11, 2021
Single-Cell Analysis of BRAF<sup>V600E</sup> and NRAS<sup>Q61R</sup> Mutation Status in Melanoma Cell Lines as Method Generation for Circulating Melanoma Cells
Joseph W Po, Yafeng Ma, Alison W S Luk, et al.
Breast (Edinburgh, Scotland)
|
November 8, 2020
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio
Clara Inkyung Lee, Siew Kee Low, Ricardo Maldonado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study
Peter Fox, Rosemary L Balleine, Clara Lee, et al.
Clinical Pharmacokinetics
|
November 16, 2013
Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study
Jacqueline S L Kloth, Heinz-Josef Klümpen, Huixin Yu, et al.
The Lancet. Oncology
|
September 18, 2024
Sequential [<sup>177</sup>Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study
Arun A Azad, Mathias Bressel, Hsiang Tan, et al.
Page
of 3